Temovate E Topical Ointment 0.05pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Temovate E: Topical ointment (0.05%)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

CLOBETASOL (kloe BAY ta sol) is a corticosteroid. It is used on the skin to treat itching, redness, and swelling caused by some skin conditions.

In-Depth Information

Temovate E 0.05% Topical Ointment

NDC: 514790454
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Psoriasis

Sometimes used for but not FDA approved for the following conditions:
Alopecia, Urticaria, Contact Dermatitis, Discoid Lupus Erythematosus, Eczema, Keloids, Rhus Dermatitis, Erythema Multiforme, Sarcoidosis, Pemphigus, Atopic Dermatitis, Lichen Planus, Granuloma Annulare, Pityriasis Rosea, Lichen Simplex, Lichen Striatus, Exfoliative Dermatitis, Aphthous Ulcer, Necrobiosis Lipoidica Diabeticorum

Storage Information
Store at room temperature (between 59 to 86 degrees F)
Temovate E 0.05% Topical Ointment

Reported Side Effects for Temovate E 0.05% Topical Ointment

Drug-Induced Acne Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Spider Veins Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Striae Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Sweat Rash Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Ambras Syndrome Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Unusual Skin Lightening Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Inflamed Hair Follicles Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Thinning Of Skin Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Infection Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Dry Skin Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Rash With Pustules Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
1.0-10.0%*
Severity: MILD
Onset: RAPID
Skin Redness Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: EARLY
Skin Irritation Incidence:
2.0-10.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
First Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Second Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Third Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Temovate E

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5